• In recent weeks, Teradar announced it had completed a US$1,899,778 U.S. Army SBIR Phase II contract, working with Lockheed Martin to test next-generation terahertz sensing for improved visibility and threat detection in harsh battlefield conditions.
• This collaboration highlights how Lockheed Martin is tying advanced sensing, autonomy, and quantum research into its platforms while also expanding production capacity to meet elevated defense demand.
• We’ll now examine how this push into terahertz sensing alongside broader production expansion could influence Lockheed Martin’s existing investment narrative.

We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Lockheed Martin Investment Narrative Recap

To own Lockheed Martin, you have to believe in sustained demand for its high end defense systems, supported by a deep backlog and ongoing modernization programs. Right now, the most important near term catalyst is the plan to ramp munitions and platform output for active conflicts, while the biggest risk is further profit pressure from legacy fixed price contracts and potential budget shifts away from key programs like the F 35. The Teradar terahertz sensing collaboration is incremental to this story, not a material near term driver.

Among recent announcements, the new research initiative with Xanadu on quantum machine learning fits closely with the Teradar news, because both point to Lockheed Martin leaning into advanced sensing, autonomy, and AI adjacent technologies. For investors focused on catalysts, this pairing matters: it shows the company working to stay relevant as defense spending gradually tilts toward more software heavy, data driven, and next generation sensing solutions, even as current returns still hinge on large legacy programs.

But while demand looks strong today, investors should also be aware that future defense budgets could tilt away from big hardware programs like the F 35 and...

Lockheed Martin's narrative projects $81.0 billion revenue and $7.1 billion earnings by 2028.

Uncover how Lockheed Martin's forecasts yield a $652.53 fair value, in line with its current price.

Exploring Other Perspectives

Some of the lowest analysts were already cautious, assuming only about 3.7% annual revenue growth to roughly US$80.1 billion by 2028, even as combat use of systems like PAC 3 and F 35 increases. Their more pessimistic view can sit uncomfortably beside fresh news on terahertz sensing and quantum research, and it is exactly this gap between cautious forecasts and new developments that you should explore further.

Explore 17 other fair value estimates on Lockheed Martin - why the stock might be worth 33% less than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Lockheed Martin research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Lockheed Martin research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lockheed Martin's overall financial health at a glance.

Seeking Other Investments?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 50 companies with promising cash flow potential yet trading below their fair value.
• This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.